Download these slides from a live Webinar for the latest evidence on targeted therapy focused on MEK inhibitors for the management of plexiform neurofibromas in patients with NF1.
Download these slides from a live Webinar for an overview of the pathophysiology of NF1 and the latest evidence on the management of patients with NF1.
Download these summary slides from a live Webinar for expert insight on the management of patients with NF1 and plexiform neurofibromas including the latest evidence on MEK inhibitors for these patients.
In this interactive on-demand webcast, expert faculty will discuss the pathophysiology and management of neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas.
In this podcast episode, listen to Scott R. Plotkin, MD, PhD, and Brian D. Weiss, MD, as they answer questions on managing NF1 and using MEK inhibitors for NF1-associated plexiform neurofibromas.
Download this short summary of key takeaways from a podcast on managing patients with NF1 including the use of MEK inhibitors for plexiform neurofibromas.